Education
About Us
Working with TipRanks
Follow Us
Shandong Boan Biotechnology Company., Limited. Class H (HK:6955)
:6955
6955 Stock Chart & Stats
HK$8.98
-HK$0.09(-1.04%)
At close: 4:00 PM EST
HK$8.98
-HK$0.09(-1.04%)
Day’s Range― - ―
52-Week RangeHK$7.71 - HK$25.00
Previous CloseN/A
Volume154.80K
Average Volume (3M)9.51M
Market Cap
HK$5.59B
Enterprise ValueHK$6.81B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)146.0
Beta0.51
Next Earnings
Mar 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding622,333,700
10 Day Avg. Volume4,853,485
30 Day Avg. Volume9,506,743
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Shandong Boan Biotechnology Company., Limited. Class H News
6955 FAQ
What was Shandong Boan Biotechnology Company., Limited. Class H’s price range in the past 12 months?
Shandong Boan Biotechnology Company., Limited. Class H lowest stock price was HK$7.71 and its highest was HK$25.00 in the past 12 months.
What is Shandong Boan Biotechnology Company., Limited. Class H’s market cap?
Shandong Boan Biotechnology Company., Limited. Class H’s market cap is HK$5.59B.
When is Shandong Boan Biotechnology Company., Limited. Class H’s upcoming earnings report date?
Shandong Boan Biotechnology Company., Limited. Class H’s upcoming earnings report date is Mar 30, 2026 which is in 97 days.
How were Shandong Boan Biotechnology Company., Limited. Class H’s earnings last quarter?
Shandong Boan Biotechnology Company., Limited. Class H released its earnings results on Aug 27, 2025. The company reported HK$0.044 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.044.
Is Shandong Boan Biotechnology Company., Limited. Class H overvalued?
According to Wall Street analysts Shandong Boan Biotechnology Company., Limited. Class H’s price is currently Overvalued.
Does Shandong Boan Biotechnology Company., Limited. Class H pay dividends?
Shandong Boan Biotechnology Company., Limited. Class H does not currently pay dividends.
What is Shandong Boan Biotechnology Company., Limited. Class H’s EPS estimate?
Shandong Boan Biotechnology Company., Limited. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shandong Boan Biotechnology Company., Limited. Class H have?
Shandong Boan Biotechnology Company., Limited. Class H has 622,333,700 shares outstanding.
What happened to Shandong Boan Biotechnology Company., Limited. Class H’s price movement after its last earnings report?
Shandong Boan Biotechnology Company., Limited. Class H reported an EPS of HK$0.044 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.794%.
Which hedge fund is a major shareholder of Shandong Boan Biotechnology Company., Limited. Class H?
Currently, no hedge funds are holding shares in HK:6955
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shandong Boan Biotechnology Company., Limited. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.45%
12-Months-Change
Fundamentals
Return on Equity
1.85%
Trailing 12-Months
Asset Growth
37.41%
Trailing 12-Months
Company Description
Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialisation of high quality biologics in China and worldwide. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology.
Shandong Boan Biotechnology Company., Limited. Class H (6955) Earnings & Revenues
Technical Analysis
Alphamab Oncology
―
Ascletis Pharma, Inc.
―
HBM Holdings Ltd.
―
Abbisko Cayman Limited
―
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―
Options Prices
Currently, No data available
---